Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 09, 2009

Impax Laboratories Acquires Rights to Abbreviated New Drug Applications

Dec 03, 2009

Amneal Receives FDA Approval for Nizatidine Oral Solution, The First Generic Oral Solution for Axid® In The Market

Dec 02, 2009

Impax Laboratories Acquires Rights to Abbreviated New Drug Applications

Nov 24, 2009

Global Pharmaceuticals Awards Grant to Myasthenia Gravis Alliance

Nov 10, 2009

Impax Laboratories to Present at the Credit Suisse 18th Annual Healthcare Conference

Nov 03, 2009

Impax Laboratories Continues Trend of Solid Growth in Revenue, Profit and Earnings for the Third Quarter 2009

Oct 30, 2009

Impax Laboratories Confirms Patent Challenge Relating to TRICOR(R) 48mg and 145mg Tablets

Oct 26, 2009

Impax Pharmaceuticals Initiates Second Phase III Trial of IPX066 in Parkinson's Disease

Oct 13, 2009

Impax Laboratories to Host Third Quarter 2009 Earnings Conference Call and Webcast on November 3

Oct 07, 2009

Impax Laboratories Settles Pending Litigation for FLOMAX(R)

Oct 05, 2009

Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules

Oct 01, 2009

Impax Laboratories Commences Shipment of Generic Adderall XR(R) Capsules, 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg

Sep 28, 2009

Impax Laboratories to Present at the JMP Securities Healthcare Focus Conference

Sep 21, 2009

Impax Laboratories Confirms Patent Challenge Relating to ORACEA(R) Delayed-Release Capsules, 40mg

Sep 21, 2009

Impax Pharmaceuticals Reports Positive Results of Phase II Trial of IPX066, a Novel Formulation of Carbidopa-Levodopa for Parkinson’s Disease

Sep 16, 2009

Impax to Present at the UBS Global Life Sciences Conference

Sep 08, 2009

Impax to Present at the Morgan Stanley Global Healthcare Conference

Aug 24, 2009

Impax Laboratories to Ring NASDAQ Opening Bell

Aug 05, 2009

Impax Laboratories Receives Final FDA Approval for Generic Depakote(R) Extended-Release 500mg Tablets

Aug 04, 2009

Impax Laboratories Reports Second Quarter 2009 Financial Results

Jul 13, 2009

Impax to Host Second Quarter 2009 Earnings Conference Call and Webcast on August 4

Jun 15, 2009

Amneal Expands Generic Portfolio With Launch of Alprazolam ER and Benazepril HCI Tablets

Jun 15, 2009

Impax Laboratories to be Added to Russell 3000(R) Index and NASDAQ Biotechnology Equal Weighted Index

Jun 03, 2009

Impax to Present at Upcoming Investor Conferences

May 19, 2009

Impax Receives FDA Approval for Generic Precose(R) Tablets, 25 mg, 50 mg and 100 mg

May 11, 2009

Impax Laboratories Added to NASDAQ Biotechnology Index

May 09, 2009

Amneal Receives Rare FDA Approval For Extended Phenytoin Sodium Capsules, USP

May 09, 2009

Amneal Receives FDA Approval For Its Second Liquid Rx Product, Prednisolone Sodium Phosphate, USP

May 06, 2009

Impax to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference May 13

May 06, 2009

Impax Receives Final FDA Approval for Generic Depakote(R) Extended-Release 250mg Tablets

May 05, 2009

Impax Reports Improved First Quarter 2009 Revenue and Profit

Apr 28, 2009

Impax to Host First Quarter 2009 Earnings Conference Call and Webcast on May 5

Apr 20, 2009

Impax Pharmaceuticals Reports Positive Achievements on its Two Leading Brand Product Candidates IPX066 and IPX056

Apr 06, 2009

Impax Confirms Patent Challenge Relating to Renvela(R) 800 mg Tablets

Mar 20, 2009

Impax Confirms Patent Lawsuit Relating to Doryx(R) Tablets 150 mg

Mar 19, 2009

Impax Pharmaceuticals to Co-Promote Wyeth's Pristiq(R)

Mar 17, 2009

Impax Confirms Patent Challenge Relating to RENAGEL(R) Tablets, 400 mg and 800 mg

Mar 17, 2009

Impax Confirms ANDA Filing for Doryx(R) Tablets 150 mg

Mar 12, 2009

IMPAX Common Stock to Begin Trading on NASDAQ

Mar 12, 2009

Impax to Present at the Cowen and Company 29th Annual Health Care Conference March 18

Mar 09, 2009

Amneal Successfully Completes Technology/Site Transfers For Acebutolol And Flecainide

Mar 03, 2009

Impax to Present at the Barclays Capital Global Healthcare Conference

Feb 26, 2009

IMPAX Reports Fourth Quarter and Full Year 2008 Financial Results

Feb 24, 2009

IMPAX to Host Fourth Quarter and Full Year 2008 Earnings Conference Call and Webcast on February 26

Feb 05, 2009

IMPAX Receives Final FDA Approval for Generic SOLODYN Extended-Release Tablets, 45mg, 90mg and 135mg

Jan 27, 2009

IMPAX Resolves Remaining SEC Comments on Form 10 Registration Statement

Jan 23, 2009

IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules

Jan 21, 2009

IMPAX Laboratories Adopts Shareholder Rights Plan

Jan 15, 2009

Impax Comments On Recent Stock Trading

Jan 08, 2009

Impax Confirms Patent Challenge Relating to Amrix (R) Extended-Release Capsules, 15mg and 30mg

Jan 07, 2009

Impax To Present at the 27th Annual J.P. Morgan Healthcare Conference

Jan 05, 2009

Impax Appoints Christopher Mengler, R. PH., President of Global Pharmaceuticals Division

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.15.0.14